RxDoctor Payments Data

Annette Reynolds, MD

Psychiatry · Erlanger, KYNPI 1215163563

Payments from drug & device makers

$401in general payments, 2019–2025

Across 30 payments — averaging $13.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$175
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$68
  • Otsuka America Pharmaceutical, Inc.$56
  • Lundbeck LLC$43
  • Ironshore Pharmaceuticals Inc.$24
  • Johnson & Johnson$19
  • plus $16 from 1 others

What the payments were for

  • Food & beverage$35288%
  • Education$4912%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$401 in reported general payments places this provider in the 50th percentile of 348 psychiatry providers in Kentucky.

See all psychiatry providers in Kentucky

Medicare billing

Part B allowed, 2024
$23,223
Medicare patients
46
Services billed
195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl31$46,542
RexultiBrexpiprazole31$44,397
TrintellixVortioxetine Hydrobromide38$27,955
Aripiprazole126$7,093
Adzenys Xr-OdtAmphetamine12$5,859
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine217$4,973
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine56$3,929
Modafinil11$2,703
Bupropion XlBupropion Hcl151$2,304
Desvenlafaxine Succinate ErDesvenlafaxine Succinate62$2,133
Clorazepate Dipotassium21$2,055
Clonazepam227$1,832
Quetiapine Fumarate140$1,784
Oxcarbazepine18$1,375
Ziprasidone Hcl27$1,329

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$175$46,54231 claims
Otsuka America Pharmaceutical, Inc.Rexulti$56$44,39731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 348 psychiatry providers in Kentucky.

Other psychiatry in Erlanger

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →